Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China

被引：0

作者：

Rui Hua

Fei Kong

Guangming Li

Xiaofeng Wen

Yuexin Zhang

Xingxiang Yang

Chenxin Meng

Wen Xie

Yongfang Jiang

Xiaozhong Wang

Xueji Han

Yan Huang

Qing Mao

Jiefei Wang

Yujuan Guan

Jiayu Chen

Yingjie Ma

Qingfang Xiong

Hong Ma

Xuebing Yan

Huiying Rao

Yingren Zhao

Tong Sun

Liying Zhu

Xiaorong Mao

Jianqi Lian

Guojiong Deng

Yongning Xin

Yifei Wang

Yinong Ye

Bin Xu

Hainv Gao

Youwen Tan

Dongliang Li

Dongliang Yang

Minghua Su

Xiaomeng Zhang

Jie Min

Xinsheng Shi

Lai Wei

Junqi Niu

机构：

[1] The First Hospital of Jilin University,Center of Infectious Diseases and Pathogen Biology, Department of Hepatology, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, State Key Laboratory of Zoonotic Disease

[2] Beijing Tsinghua Changgung Hospital,Tangdu Hospital

[3] Zhengzhou Sixth People’s Hospital,Union Hospital, Tongji Medical College

[4] Liuzhou People’s Hospital,undefined

[5] The First Hospital Affiliated to Xinjiang Medical University,undefined

[6] Sichuan Provincial People’s Hospital,undefined

[7] The Sixth People’s Hospital of Shenyang,undefined

[8] Beijing Ditan Hospital Affiliated with Capital Medical University,undefined

[9] The Second Xiangya Hospital of Central South University,undefined

[10] Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine,undefined

[11] Affiliated Hospital of Yanbian University,undefined

[12] Xiangya Hospital,undefined

[13] Central South University,undefined

[14] The First Affiliated Hospital of Army Military Medical University,undefined

[15] Shanghai Public Health Clinical Center,undefined

[16] Guangzhou Eighth People’s Hospital,undefined

[17] The 940th Hospital of Joint Logistics Support Force of PLA,undefined

[18] Zhengzhou People’s Hospital,undefined

[19] The Second Hospital of Nanjing,undefined

[20] Beijing Friendship Hospital Affiliated with Capital Medical University,undefined

[21] The Affiliated Hospital of Xuzhou Medical University,undefined

[22] Peking University People’s Hospital,undefined

[23] The First Affiliated Hospital of Xi’an Jiaotong University,undefined

[24] The Fifthth People’s Hospital of Wuxi,undefined

[25] The Fourth Affiliated Hospital of Harbin Medical University,undefined

[26] The First Hospital of Lanzhou University,undefined

[27] The Fourth Military Medical University of the PLA,undefined

[28] Jiangyin People’s Hospital,undefined

[29] Qingdao Municipal Hospital,undefined

[30] Tonghua Central Hospital,undefined

[31] Foshan First People’s Hospital,undefined

[32] Beijing You’an Hospital Affiliated with Capital Medical University,undefined

[33] Shulan (Hangzhou) Hospital,undefined

[34] The Third People’s Hospital of Zhenjiang,undefined

[35] The 900Th Hospital of Joint Logistics Support Force of PLA,undefined

[36] Huazhong University of Science and Technology,undefined

[37] The First Affiliated Hospital of Guangxi Medical University,undefined

[38] Nanjing Sanhome Pharmaceutical Co.,undefined

[39] Ltd,undefined

来源：

Infectious Diseases and Therapy | 2023年 / 12卷

关键词：

Alfosbuvir; Daclatasvir; Hepatitis C virus; China;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2595 / 2609

页数：14

共 50 条

[1] Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China
Hua, Rui
Kong, Fei
Li, Guangming
Wen, Xiaofeng
Zhang, Yuexin
Yang, Xingxiang
Meng, Chenxin
Xie, Wen
Jiang, Yongfang
Wang, Xiaozhong
Han, Xueji
Huang, Yan
Mao, Qing
Wang, Jiefei
Guan, Yujuan
Chen, Jiayu
Ma, Yingjie
Xiong, Qingfang
Ma, Hong
Yan, Xuebing
Rao, Huiying
Zhao, Yingren
Sun, Tong
Zhu, Liying
Mao, Xiaorong
Lian, Jianqi
Deng, Guojiong
Xin, Yongning
Wang, Yifei
Ye, Yinong
Xu, Bin
Gao, Hainv
Tan, Youwen
Li, Dongliang
Yang, Dongliang
Su, Minghua
Zhang, Xiaomeng
Min, Jie
Shi, Xinsheng
Wei, Lai
Niu, Junqi
INFECTIOUS DISEASES AND THERAPY, 2023, 12 (11) : 2595 - 2609
[2] ASUNAPREVIR PLUS DACLATASVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION
Zeuli, J. D.
Adie, S. K.
Rizza, S. A.
Temesgen, Z.
DRUGS OF TODAY, 2015, 51 (11) : 629 - 643
[3] DACLATASVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION
Temesgen, Z.
Rizza, S. A.
DRUGS OF TODAY, 2015, 51 (05) : 277 - 288
[4] Daclatasvir for the treatment of hepatitis C virus infection
Adler, Hugh
Lambert, John S.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) : 725 - 738
[5] Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection
Zeuzem, Stefan
Hezode, Christophe
Bronowicki, Jean-Pierre
Loustaud-Ratti, Veronique
Gea, Francisco
Buti, Maria
Olveira, Antonio
Banyai, Tivadar
Al-Assi, M. Tarek
Petersen, Joerg
Thabut, Dominique
Gadano, Adrian
Pruitt, Ronald
Makara, Mihaly
Bourliere, Marc
Pol, Stanislas
Beumont-Mauviel, Maria
Ouwerkerk-Mahadevan, Sivi
Picchio, Gaston
Bifano, Marc
McPhee, Fiona
Boparai, Navdeep
Cheung, Kin
Hughes, Eric A.
Noviello, Stephanie
JOURNAL OF HEPATOLOGY, 2016, 64 (02) : 292 - 300
[6] Dual daclatasvir and sofosbuvir for treatment of genotype 3 chronic hepatitis C virus infection
Sundaram, Vinay
Kowdley, Kris V.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (01) : 13 - 20
[7] NS5A inhibitor, daclatasvir, for the treatment of chronic hepatitis C virus infection
Herbst, D. Alan
Reddy, K. Rajender
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (10) : 1337 - 1346
[8] Review article: the efficacy and safety of daclatasvir in the treatment of chronic hepatitis C virus infection
Bunchorntavakul, C.
Reddy, K. R.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (03) : 258 - 272
[9] Evaluation of sofosbuvir plus daclatasvir combination for hepatitis C virus treatment
Moron Romero, Rocio
Diaz, Xando
del Carmen Gonzalez, Maria
Rodriguez, Alejandro
Casas, Inmaculada
Cabeza, Jose
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 331 - 331
[10] Daclatasvir for the treatment of chronic hepatitis C
Degasperi, Elisabetta
Aghemo, Alessio
Colombo, Massimo
EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (17) : 2679 - 2688

← 1 2 3 4 5 →